A blood test for glioblastoma may be on the horizons, as researchers identify novel biomarkers that could be used for diagnosis.
In a revolutionary approach, Cognetivity (London, UK) have created a new test for detecting dementia and Alzheimer’s disease by focusing on image cognition and the brain’s ability to analyze visual information.
Three novel radiopharmaceuticals have been evaluated for their potential to be utilized in PET imaging of tau proteins in humans. The results of the study have the potential to improve the way we diagnose and treat Alzheimer’s disease.
A team of researchers have devised a novel method of diagnosing autism in children. Following analysis of short home videos of children, mathematical modelling was utilized to provide a numerical score indicating the severity of the developmental disorder.
Researchers from Ludwig Maximilian University have developed a simple walking test to diagnose idiopathic normal pressure hydrocephalus, a cause of dementia.
In this review article from Neurodegenerative Disease Management, discover how Parkinson’s disease psychosis may be optimally diagnosed and managed to improve quality of life.
Detecting caffeine levels in the blood may help to diagnose Parkinson’s disease, especially in its early stages.
This review from Biomarkers in Medicine explores the potential use of blood cell biomarkers in diagnosing Alzheimer’s disease as an alternative to traditional methods.
A recent study has suggested that physicians could determine whether a patient has major depression or bipolar disorder with a simple short electrocardiogram.
Salivary biomarkers have proven more accurate for identifying prolonged concussion than current methods.